Is US residence a risk factor for Alzheimer's disease?
Poul F Høilund-Carlsen1,2, Abass Alavi3, Tommaso Costa4,5
1Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
None:
Reducing risk factors is a useful way to counteract diseases. The prevalence of Alzheimer's disease (AD) in the US is often quoted as 6.9 million out of 333 million people, or 2.1%. It is around 0.7% in the UK, 0.9% in Denmark, and worldwide the estimate is 0.5%. Alongside risk factor reduction, the Centers for Medicare and Medicaid Services could strengthen the US fight against AD by reconsidering its October 2023 decision to liberalize reimbursement of amyloid PET scans, or better yet, advise replacing these non-specific scans with FDG-PET, which shows what AD is really about: impaired regional brain function.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Psychoneuroimmunology: Diabetes and Cancer
Cognitive Development During Adulthood
Psychological and Sociocultural Causes of Schizophrenia
